Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Consulting agrmnt
Upcoming conference date
Acq. announced
Director departure
Appointed director
Employment agrmnt
Quarterly results
RespireRx Pharmaceuticals Inc. (CORX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2018 8-K/A Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
07/17/2017 8-K/A Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Ampakine Executive Summary"
04/12/2016 8-K/A Form 8-K/A - Current report [Amend]
11/02/2015 8-K/A Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "Employment Agreement between Cortex Pharmaceuticals, Inc. and James S. J. Manuso",
"Employment Agreement between Cortex Pharmaceuticals, Inc. and Arnold S. Lippa",
"Employment Agreement between Cortex Pharmaceuticals, Inc. and Robert N. Weingarten",
"Employment Agreement between Cortex Pharmaceuticals, Inc. and Jeff E. Margolis"
07/10/2015 8-K/A Financial Statements and Exhibits
Docs: "Revised Slides amending certain slides furnished as to the Company’ s Current Report on Form 8-K filed July 9, 2015"
05/18/2015 8-K/A Financial Statements and Exhibits
Docs: "Revised Slides amending certain slides furnished as to the Company’ s Current Report on Form 8-K filed May 1, 2015"
06/16/2014 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Audited financial statements of Pier (formerly SteadySleep Rx Co.) for the years ended December 31, 2011 and 2010, and for the period from June 25, 2007 (inception) to December 31, 2011 (cumulative), and the notes related thereto",
"Unaudited financial statements of Pier (formerly SteadySleep Rx Co.) for the years ended June 30, 2012 and 2011, and for the period from June 25, 2007 (inception) to June 30, 2012 (cumulative), and the notes related thereto",
"Unaudited pro forma condensed consolidated balance sheet as of June 30, 2012",
"Unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2011 and for the six months ended June 30, 2012"
12/01/2004 8-K/A Auditor change
Docs: "Letter from Ernst & Young LLP to the U.S. Securities & Exchange Commission",
"LETTER TO THE SEC STAFF"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy